Repertaxin

CAS No. 266359-83-5

Repertaxin( Repertaxin | DF 1681Y )

Catalog No. M17461 CAS No. 266359-83-5

Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 65 In Stock
5MG 110 In Stock
10MG 177 In Stock
25MG 372 In Stock
50MG 556 In Stock
100MG 791 In Stock
500MG 1575 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Repertaxin
  • Note
    Research use only, not for human use.
  • Brief Description
    Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
  • Description
    Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Repertaxin | DF 1681Y
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CXCR1| CXCR2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    266359-83-5
  • Formula Weight
    283.39
  • Molecular Formula
    C14H21NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 500 mg/mL; 1764.35 mM
  • SMILES
    CS(=O)(=O)NC(=O)[C@@H](c1ccc(CC(C)C)cc1)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moriconi A, et al. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. J Med Chem. 2007 Aug 23;50(17):3984-4002.
molnova catalog
related products
  • CB 65

    CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.

  • TM38837

    TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.

  • LDK1229

    LDK1229 is a novel potent, selective cannabinoid CB1 receptor inverse agonist with Ki of 220 nM.